Integrated Investment Consultants’s Pfizer PFE Stock Holding History

Integrated Investment Consultants’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.32M	Sell	54,751 -581	-1%	-$15.2K	0.26%	64
2026 Q1	$1.55M	Buy	55,332 +4,320	+8%	+$115K	0.33%	54
2025 Q4	$1.27M	Buy	51,012 +25,861	+103%	+$652K	0.25%	70
2025 Q3	$641K	Buy	25,151 +1,113	+5%	+$27.5K	0.11%	120
2025 Q2	$583K	Sell	24,038 -8,027	-25%	-$187K	0.11%	128
2025 Q1	$813K	Sell	32,065 -17,240	-35%	-$451K	0.16%	102
2024 Q4	$1.31M	Sell	49,305 -63,580	-56%	-$1.72M	0.27%	68
2024 Q3	$920K	Buy	112,885 +90,910	+414%	+$2.65M	0.2%	75
2024 Q2	$610K	Hold	21,975	–	–	0.17%	106
2024 Q1	$610K	Sell	21,975 -3,176	-13%	-$88.1K	0.17%	106
2023 Q4	$724K	Buy	25,151 +4,777	+23%	+$144K	0.23%	76
2023 Q3	$676K	Sell	20,374 -1,950	-9%	-$69K	0.25%	66
2023 Q2	$819K	Sell	22,324 -112	-0.5%	-$4.36K	0.26%	60
2023 Q1	$915K	Buy	22,436 +804	+4%	+$34.7K	0.29%	47
2022 Q4	$1.11M	Buy	21,632 +608	+3%	+$29.1K	0.37%	41
2022 Q3	$920K	Sell	21,024 -2,466	-10%	-$120K	0.37%	41
2022 Q2	$1.23M	Sell	23,490 -1,292	-5%	-$65.8K	0.45%	37
2022 Q1	$1.28M	Sell	24,782 -2,768	-10%	-$144K	0.35%	42
2021 Q4	$1.63M	Sell	27,550 -391	-1%	-$19.4K	0.43%	33
2021 Q3	$1.2M	Buy	27,941 +213	+0.8%	+$9.44K	0.35%	45
2021 Q2	$1.09M	Buy	27,728 +931	+3%	+$36.2K	0.32%	50
2021 Q1	$971K	Sell	26,797 -3,200	-11%	-$114K	0.33%	47
2020 Q4	$1.1M	Sell	29,997 -1,271	-4%	-$46.6K	0.42%	44
2020 Q3	$1.09M	Sell	31,268 -1,053	-3%	-$36.9K	0.51%	35
2020 Q2	$1M	Sell	32,321 -101	-0.3%	-$3.43K	0.48%	37
2020 Q1	$1M	Sell	32,422 -228	-0.7%	-$7.77K	0.59%	34
2019 Q4	$1.21M	Sell	32,650 -3,210	-9%	-$114K	0.5%	40
2019 Q3	$1.22M	Buy	35,860 +3,261	+10%	+$119K	0.63%	31
2019 Q2	$1.34M	Buy	32,599 +775	+2%	+$30.8K	0.69%	30
2019 Q1	$1.28M	Sell	31,824 -4,799	-13%	-$192K	0.68%	30
2018 Q4	$1.52M	Sell	36,623 -4,174	-10%	-$173K	0.81%	22
2018 Q3	$1.71M	Sell	40,797 -1,160	-3%	-$44.7K	0.83%	18
2018 Q2	$1.44M	Sell	41,957 -1,843	-4%	-$63K	0.76%	19
2018 Q1	$1.48M	Buy	+43,800	New	+$1.51M	0.58%	22
2017 Q3	$1.68M	Buy	49,578 +745	+2%	+$23.9K	0.73%	18
2017 Q2	$1.56M	Sell	48,833 -174	-0.4%	-$5.49K	0.7%	18
2017 Q1	$1.59M	Buy	49,007 +791	+2%	+$24.9K	0.73%	17
2016 Q4	$1.49M	Buy	48,216 +2,266	+5%	+$69.2K	0.71%	18
2016 Q3	$1.43M	Buy	45,950 +421	+0.9%	+$14.1K	0.73%	18
2016 Q2	$1.52M	Buy	45,529 +2,099	+5%	+$67K	0.86%	17
2016 Q1	$1.34M	Buy	43,430 +422	+1%	+$12.1K	0.77%	18
2015 Q4	$1.25M	Buy	+43,008	New	+$1.35M	0.99%	17

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Integrated Investment Consultants's PFE Position: Q2 2026 in Review

Integrated Investment Consultants reduced its Pfizer (PFE) stake by 1.1% in Q2 2026, selling an estimated $15.2K and leaving 54,751 shares worth $1.32M. The position accounts for 0.26% of the portfolio, ranked #64.

Integrated Investment Consultants first reported a position in PFE in Q4 2015 and has held it in 42 quarters since. The position peaked at $1.71M in Q3 2018. 2,823 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Integrated Investment Consultants held 54,751 shares of Pfizer worth $1.32M as of Q2 2026.
Integrated Investment Consultants sold 581 Pfizer shares in Q2 2026, an estimated $15.2K.
Pfizer made up 0.26% of Integrated Investment Consultants's portfolio in Q2 2026, its #64 holding.
Integrated Investment Consultants first reported a position in Pfizer in Q4 2015 and has held it in 42 quarters since.
Integrated Investment Consultants's Pfizer position peaked at $1.71M in Q3 2018.
2,823 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Integrated Investment Consultants's 13F filing for Q2 2026, filed 17 Aug 2026.